Cargando…

World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat

Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Hidekazu, Mori, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847180/
https://www.ncbi.nlm.nih.gov/pubmed/29138921
http://dx.doi.org/10.1007/s00535-017-1407-1
_version_ 1783305703293714432
author Suzuki, Hidekazu
Mori, Hideki
author_facet Suzuki, Hidekazu
Mori, Hideki
author_sort Suzuki, Hidekazu
collection PubMed
description Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering regional differences in resistance to clarithromycin and metronidazole. Quinolones and rifabutin-containing regimens are useful as third- and fourth-line rescue therapies.
format Online
Article
Text
id pubmed-5847180
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-58471802018-03-20 World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat Suzuki, Hidekazu Mori, Hideki J Gastroenterol Review Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering regional differences in resistance to clarithromycin and metronidazole. Quinolones and rifabutin-containing regimens are useful as third- and fourth-line rescue therapies. Springer Japan 2017-11-14 2018 /pmc/articles/PMC5847180/ /pubmed/29138921 http://dx.doi.org/10.1007/s00535-017-1407-1 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Suzuki, Hidekazu
Mori, Hideki
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
title World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
title_full World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
title_fullStr World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
title_full_unstemmed World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
title_short World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
title_sort world trends for h. pylori eradication therapy and gastric cancer prevention strategy by h. pylori test-and-treat
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847180/
https://www.ncbi.nlm.nih.gov/pubmed/29138921
http://dx.doi.org/10.1007/s00535-017-1407-1
work_keys_str_mv AT suzukihidekazu worldtrendsforhpylorieradicationtherapyandgastriccancerpreventionstrategybyhpyloritestandtreat
AT morihideki worldtrendsforhpylorieradicationtherapyandgastriccancerpreventionstrategybyhpyloritestandtreat